603.20
-10.60
(-1.73%)
At close: 5:32:33 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 24 | 24 | 29 | 29 |
| Avg. Estimate | 3.83B | 7.51B | 18.28B | 20.53B |
| Low Estimate | 3.8B | 7.35B | 18.18B | 20.28B |
| High Estimate | 3.85B | 7.58B | 18.34B | 20.84B |
| Year Ago Sales | 3.39B | 6.74B | 16.29B | 18.28B |
| Sales Growth (year/est) | 13.04% | 11.49% | 12.25% | 12.30% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INTU.VI | -- | -- | -- | -- |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Reiterates | Piper Sandler: Overweight to Overweight | 1/10/2025 |
| Maintains | Jefferies: Buy to Buy | 11/22/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 11/22/2024 |
| Maintains | Stifel: Buy to Buy | 11/22/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 11/22/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/22/2024 |